Article
What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity.
Science signaling - 24 Sept 2013
Quaranta Vito, Tyson Darren R
Abstract excerpt
The identification of "driver mutations" in cancers initiated rapid development of targeted drugs for the clinic. Despite promising outcomes initially in patients, the ultimate success of oncogene-targeted drugs has been hampered by the redundancy and remarkable complexity of cellular signaling pathways. Two studies in Science Signaling show that understanding these intricate networks and considering them during...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
